Fitch D D, Wilson J A
South Med J. 1985 Aug;78(8):909-13. doi: 10.1097/00007611-198508000-00004.
We studied 56 patients with primary gastrointestinal lymphoma to determine the manifestations, diagnostic and treatment methods, and patient outcomes. We identified 27 cases of primary gastric lymphoma and 29 cases of lymphoma involving the remainder of the gastrointestinal tract. Initial symptoms were nonspecific and included abdominal pain, weight loss, nausea, and vomiting. Diagnosis was frequently made at operation, with less than half of the patients having endoscopy and biopsy. The predominant histologic type was diffuse histiocytic lymphoma; the second most common type was poorly differentiated lymphocytic lymphoma. Average survival for patients with gastric lymphomas was 38 months, versus 21 months for those with intestinal lymphomas. The most important prognostic factor was the stage of disease at presentation; spread beyond the regional lymph nodes was associated with shortened survival. Comparison of treatment groups was compromised by the varied combinations of therapy used and by the stages and sites of disease. This study points out the need for prospective randomized clinical trials, with comprehensive staging and uniform therapeutic procedures, to identify the best available methods.
我们研究了56例原发性胃肠道淋巴瘤患者,以确定其临床表现、诊断和治疗方法以及患者的预后情况。我们确定了27例原发性胃淋巴瘤和29例累及胃肠道其他部位的淋巴瘤。初始症状无特异性,包括腹痛、体重减轻、恶心和呕吐。诊断通常在手术时做出,不到一半的患者接受了内镜检查和活检。主要组织学类型为弥漫性组织细胞淋巴瘤;第二常见类型为低分化淋巴细胞淋巴瘤。胃淋巴瘤患者的平均生存期为38个月,而肠淋巴瘤患者为21个月。最重要的预后因素是疾病初发时的分期;超出区域淋巴结的扩散与生存期缩短有关。由于治疗方法的组合不同以及疾病的分期和部位不同,治疗组之间的比较受到了影响。本研究指出需要进行前瞻性随机临床试验,采用全面分期和统一治疗程序,以确定最佳可用方法。